Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009

...eneric competition for Depakote. This resulted in a $306 million decline in depakote sales in the second quarter, reducing reported U.S. pharmaceutical sales gr...t of foreign exchange. This occurred despite the negative impact from lower depakote sales. Q4) How did R&D and SG&A investment compare to t...

FDA Approves Lamictal(R)XR(TM); An Extended-Release Once-Daily, New Generation Treatment for Epilepsy

...lity of human life by enabling people to do more, feel better and live longer. For further information please visit www.gsk.com *Depakene and depakote are registered trademarks of Abbott Laboratories GlaxoSmithKline cautionary statement regarding forward-looking statements Under the safe har...

FDA Approves Lamictal(R) ODT(TM) Orally Disintegrating Tablets

...breakthrough bleeding, while taking Lamictal and birth control pills. These are not all the possible side effects of Lamictal. *Depakene and depakote are registered trademarks of Abbott Laboratories For full prescribing information including Boxed Warning, please visit www.lamictal.com and ...

Abbott Reports 16 Percent Earnings Growth in First Quarter; Confirms Double-Digit Earnings Growth Outlook for 2009

...hange rates, increased 0.9 percent. The decline in depakote sales lowered worldwide pharmaceutical sales growt... 9.7 (17.4) (7.7) depakote $19 (0.7) (18.7) ...of generic competition for both forms of Depakote; depakote DR and...

Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Confirms Strong Outlook for 2009 Earnings

...letra $152 (0.7) $226 3.5 b $378 1.8 depakote $244 (43.8) $24 (9.1) $268 (41.8) Niasp...letra $513 (4.7) $961 22.1 b $1,474 11.2 depakote $1,262 (14.8) $102 7.4 $1,364 (13.4) TriCo...

Despite Availability of Generic Equivalents, Two-Thirds of Neurologists Will Continue to Prescribe Branded Anti-Epileptic Drugs to Epilepsy Patients

...tion, most significantly in epilepsy, for Abbott's depakote ER. Our survey showed that 79 percent of neurologi... patients from the brand to the generic version of depakote ER. Physicians' concerns are a result of this agen...rsions of UCB's Keppra, Ortho-McNeil's Topamax and depakote ER have become available, more than half of 20 sur...

FDA Adds Suicide Warning to Epilepsy Drugs

...FDA-mandated labeling are: carbamazepine (marketed as Carbatrol, Equetro, Tegretol, Tegretol XR); clorazepate (Tranxene); divalproex sodium (Depakote, depakote ER, Depakene); ethosuximide (Zarontin); ethotoin (Peganone); felbamate (Felbatol); gabapentin (Neurontin); lamotrigine (Lamictal); lacosamide (Vimpat)...

December 2008 Mayo Clinic Health Letter Highlights: Colorectal Screenings, Lighting Tips for Low Vision and Generic Medications

...able as generic since 2006: Altace (ramipril) for blood pressure and heart failure Ambien (zolpidem), a sleep aid depakote (divalproex) for seizures, migraines and bipolar disorder Fosamax (alendronate) for osteoporosis Requip (ropinirole) for restless leg...

Jefferson researcher awarded NIH grant

...for a certain period of time following treatment. Trial participants will be randomly broken into four groups and prescribed either Dilantin, Keppra, depakote or no medication to see if there are any potential short- or long-term effects on cardiovascular risk factors. ...

Lupin Receives USFDA Approval for Divalproex Sodium Delayed-Release Tablets

...ibed alone or with other epilepsy medications. The delayed-release tablets are also used to control the manic episodes that occur in bipolar disorder. depakote had annual sales of approximately $803 million for the twelve months ended March 2008, based on IMS Health sales data. About Lupin Headquartered i...